All In Biotech

Free tool

FAERS Monitor: Inzirqo

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 219141 or its brand name (Inzirqo, Hydrochlorothiazide). Reports on generic versions are filed under their own applications.

Reports

146,340

Serious

98,133

67% of reports

Hospitalization

50,339

Death reported

10,200

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue10,470
  • nausea10,085
  • drug ineffective9,767
  • diarrhoea8,711
  • pain7,943
  • headache7,893
  • dyspnoea7,876
  • dizziness7,629
  • arthralgia6,349
  • off label use6,034
  • asthenia5,795
  • vomiting5,777
  • fall5,775
  • malaise5,387
  • acute kidney injury5,154

Reports by year received

View as table
YearReports
20042,310
20053,022
20063,005
20072,864
20083,115
20093,900
20105,287
20115,369
20125,907
20134,812
20146,176
20158,039
20168,663
20177,780
201810,001
201910,143
20209,294
20218,945
20228,828
20238,058
20247,549
20257,755
20265,513

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,907,819 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal5,1545.04.815,927
fallSignal5,7752.52.55,286
astheniaSignal5,7952.22.23,959
dizzinessSignal7,6292.22.25,139
arthralgiaSignal6,3492.22.24,240
dyspnoeaSignal7,8762.02.04,072
diarrhoea8,7112.01.94,118
fatigue10,4701.91.94,928
pain7,9431.91.83,266
nausea10,0851.81.83,982
headache7,8931.81.82,966
vomiting5,7771.81.71,976
malaise5,3871.81.71,838
drug ineffective9,7671.11.042
off label use6,0341.01.01

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.